ArticleBlood advances2024

CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model.

Lotus Neidemire-Colley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.